Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Other Accumulated Expenses (2022 - 2023)

Rallybio's Other Accumulated Expenses history spans 2 years, with the latest figure at $3.3 million for Q1 2023.

  • On a quarterly basis, Other Accumulated Expenses changed N/A to $3.3 million in Q1 2023 year-over-year; TTM through Mar 2023 was $3.3 million, a N/A change, with the full-year FY2022 number at $654000.0, changed N/A from a year prior.
  • Other Accumulated Expenses hit $3.3 million in Q1 2023 for Rallybio, up from $654000.0 in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for RLYB hit a ceiling of $3.3 million in Q1 2023 and a floor of $654000.0 in Q4 2022.